Title: Sustainable value creation in the commercialisation of innovation: the case of Auria Biobank

Authors: Hanna Lehtimäki; Ilpo Helén; Karoliina Snell; Päivi Eriksson; Tero Montonen

Addresses: Business School, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland ' Department of Social Sciences, University of Eastern Finland, P.O. Box 111, FI-80101 Joensuu, Finland ' Helsinki Institute of Science and Technology Studies, University of Helsinki, P.O. Box 18, FI-00014, Finland ' Business School, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland ' Business School, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland

Abstract: The purpose of this study is to examine how different logics of commercialisation are part of sustainable value creation in an emerging area of healthcare. This paper presents an inductive interpretative case study to examine the emerging field of personalised medicine from the perspective of a biobank seeking to create value on its depository of tissue samples, patient records, and digitised data. This study increases our understanding of the challenges and opportunities faced by a company when developing innovations in healthcare. It contributes to the literature on the commercialisation of innovation by exploring how sustainable value creation in an emerging industry builds on both planned and emergent commercialisation activities and how different logics of commercialisation are a part of sustainable value creation in personalised medicine.

Keywords: healthcare; innovation; commercialisation; value creation; stakeholder; biobank; personalised medicine.

DOI: 10.1504/IJEIM.2019.102035

International Journal of Entrepreneurship and Innovation Management, 2019 Vol.23 No.5, pp.451 - 465

Received: 06 Jun 2017
Accepted: 13 Sep 2017
Published online: 04 Sep 2019 *

Full-text access for editors Full-text access for subscribers Purchase this article Comment on this article